Introduction
Moyamoya disease (MMD) was first reported in 1957 by Shimizu and colleagues as hypoplasia of the bilateral internal carotid arteries (ICAs). Moyamoya syndrome has been used to describe a similar condition when an underlying pathology, such as atherosclerosis, radiation therapy or sickle cell disease, can be identified. The syndrome consists of unilateral or bilateral steno-occlusive arterial changes and associated Moyamoya collaterals [1] . The incidence of MMD peaks in two age groups: children who are approximately 5 years old and adults in their mid-40s [2] . Chances of having MMD are 2-fold higher in female than male [2] . Three types of research have been conducted to explain the pathogenesis of MMD: pathological analysis of affected tissue, genetic-linkage studies and studies of the role of angiogenesis and extracellular matrix-related peptides in disease development and progression. Pathological analysis has revealed that vessel occlusion is not due to arteriosclerotic or inflammatory, but is a result of smooth-muscle cell hyperplasia and luminal thrombosis [3] . Suzuki and Takaku described six separate angiographic stages of Moyamoya based on the pattern of steno-occlusion and collateral formation [4] . Grade I refers to the narrowing of the ICA apex without Moyamoya collaterals. Grade II refers to ICA stenosis along with initiation of Moyamoya collaterals. Grade III refers to progression of the ICA stenosis with intensification of Moyamoya collaterals. Grade IV refers to development of external carotid artery (ECA) collaterals. Grade V refers to intensification of ECA collaterals along with a reduction of Moyamoya collaterals. Grade VI represents the final stage of the disease process with total occlusion of the ICA and disappearance of Moyamoya collaterals [4] . The pathogenesis of MMD is irreversible despite treatment. Current available treatments are aiming to prevent stroke by improving cerebral blood flow (CBF) to the affected cerebral hemisphere. Medical therapy has been used in patients with MMD, particularly in mild cases or where surgical intervention is contraindicated. But there is few data showing either its short-term or long-term efficacy. Surgical treatment for patients with MMD typically uses the ECA as a source of new blood supply to the ischaemic hemisphere. There are two types of revascularisation: direct and indirect. In direct revascularisation, a branch of the ECA is directly anastomosed to a cortical artery. In indirect revascularisation, tissue vascularised by the ECA is placed onto the brain, leading to an ingrowth of vasculature to the underlying cerebral cortex [3] . 
Case report
A 21-year-old male presented with a history of repeated headache accompanied by vomiting for 5 days. His memory and learning ability are worse than his peers. His past history and family history are unremarkable. On examination, he was afebrile and conscious There is no papilledema or other neurological deficit. Computed tomography (CT) head showed bilateral intraventricular haemorrhage. Diagnostic digital subtraction angiography (DSA) confirmed stenosis at the bifurcation of right ICA and anterior cerebral artery (ACA) with collateral vessels (Fig. 1) . The left ICA and the ACA are partially occluded with collateral vessel formation (Fig. 1 ). CT angiography (CTA) of the head was also performed with similar findings as the DSA (Fig. 2) . Head CT perfusion (CTP) revealed a hypovolemic left cerebral hemisphere comparing to the right (Fig. 2) .
The diagnosis of bilateral MMD was established based on the above evidence, with a more severe imagine finding on the left. Diameters of the following arteries are measured by vascular ultrasonography, anterior branch of left superficial temporal artery (STA) (1.4 mm), posterior branch of STA (2.0 mm). The anterior branch of the right STA is missing and posterior branch of STA (1.5 mm). The reasonable vascular diameters improved the chances of success anastomosis. Since the lesion on the left side is severe than the right side ( Figs. 1 and 2) . A decision to perform a unilateral bypass surgery on the left side was made. The procedure of STA to middle cerebral artery (MCA) bypass was carried out giving its clinical outcomes, particularly in diminishing the incidence of recurrent ischaemic events. The patient underwent an uneventfully opera- tion with no postoperative complications. The patient was fit to be discharged on the 14th post-operative day. Head CTA 2 weeks post-operatively showed patent vascular anastomosis with newborn compensatory proliferated vasculature leading to improved CBF as demonstrated by the head CTP (Fig. 2) . One month postoperative DSA also demonstrated anastomosis patency ( Fig. 1) . At 3-year follow-up, there is no evidence of intracranial haemorrhage or other complication. Unfortunately, no more image follow-up is feasible after one month since the patient is from a distant rural area.
Discussion
We presented a unilateral surgical intervention for a 21-yearold male with bilateral symptomatic MMD by STA-MCA bypass. The direct approach by STA-MCA bypass is a reliable treatment for MMD, which can immediately improve symptoms and reduce recurrent ischaemic events. Therefore it is the procedure of choice for this patient. Although a favourable clinical outcome is observed in this case, this may not necessarily match the improvement in the haemodynamic parameters. In addition, although no evidence of long-term complication, whether this is a result of the revascularisation is unknown. Especially when there is no long-term DSA data available in this case.
The STA-MCA procedure is technically demanding and can be associated with devastating haemorrhage. Usually, direct bypass is limited to adults or older children due to the small caliber of the STA. Indirect bypass can also be considered in patient with serious medical comorbidities or in patient with inadequate recipient or donor artery grafts. Encephalomyosynangiosis, for example, is a safe and easy procedure, which can be offered in these groups of patients. However, this approach also has its disadvantages.
Firstly, it requires larger craniotomy with dura opening. Secondly, it is associated with significant postoperative complications such as seizures and/or mass effect on the brain. Thirdly, it requires longer time to establish collateral vessel formation [5] .
In recent years, surgical revascularisation is recommended in most symptomatic cases to reduce ischemic symptoms and to improve hemodynamic status [6] . Direct revascularisation in particular, provides significant improvement in this scenario [7] . However, the effect on CBF after revascularisation remains controversial. In one study, short-term follow-up after 3-6 months showed decreased CBF after direct revascularisation at the ipsilateral symptomatic hemisphere [7] . In other study, total CBF improvement can be achieved after STA-MCA bypass in symptomatic patients [8] . Evidence also showed that unilateral revascularisation could increase CBF in the contralateral nonintervened hemisphere [9] . In one study, Chen et al. demonstrated significantly improved CBF in less than 2 weeks after operation [10] . CTP was used in this study to provide a quantitative analysis of CBF before and after STA-MCA anastomosis [10] .
The most appropriate revascularisation procedure for patients with MMD is not yet well defined. Nonetheless, ample evidence suggests that surgical intervention improves the outcome of patient with symptomatic MMD. Each procedure has its own advantages and disadvantages. Direct revascularisation may lead to immediate improvement of symptoms and could decrease recurrent ischaemic events. Although technically demanding and the possibility of life-threatening haemorrhage, direct bypass remains the preferred procedure for patient with symptomatic MMD. Previously, researchers have not used standardised outcome measures to assess patients on presentation and on long-term follow-up. It is suggested that neuropsychological testing after surgical intervention is critical to accurately assess outcomes [11] . Therefore, it should be integrated into future clinical trials. Direct and indirect revascularisation will continue to play a major role in the treatment of MMD. The choice of procedure appears to depend on the surgeon's experience and on the nature of the patient's presentation. Randomised prospective clinical trial comparing the various procedures may be developed to define the most appropriate indications in different patient groups. Although beneficial presentation is evident in our patient after the unilateral STA-MCA bypass, no solid conclusion can be drawn from a single case. However, this paper opened an argument and also added one piece of evidence that unilateral direct bypass might be sufficient for patient with bilateral MMD.
